SCHEMBL23919279

SCHEMBL23919279

Cc1ccc2c(oc3ccccc32)c1N(c1cc(C(C)C)c2ccc3c(N(c4c(C)ccc5c4oc4ccccc45)c4c(C)ccc5c4oc4ccccc45)cc(C(C)C)c4ccc1c2c43)c1c(C)ccc2c1oc1ccccc12

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
PGR P06401 1/20 0.32
MAOA P21397 4/20 0.32
TNKS O95271 1/20 0.32
PARP1 P09874 1/20 0.32
TNKS2 Q9H2K2 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
PARP2 Q9UGN5 1/20 0.32
GPR55 Q9Y2T6 2/20 0.32
CNR2 P34972 1/20 0.31
NPC1 O15118 1/20 0.31
GAA P10253 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
MAOB P27338 1/20 0.31
AHR P35869 2/20 0.31
PRKDC P78527 1/20 0.31
ATM Q13315 1/20 0.31
TTR P02766 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23919509 0.94 GPR55 (0.35) MEN1KMT2ATNKSPARP1TNKS2
SCHEMBL23919276 0.93 PRKDC (0.31) MEN1KMT2APGRPRKDCATM
SCHEMBL21686948 0.93 MEN1 (0.32) MEN1KMT2APGRGPR55CNR2
SCHEMBL22568535 0.93 CNR2 (0.31) MEN1KMT2APGRGPR55CNR2
SCHEMBL23919277 0.91 PGR (0.31) MEN1KMT2APGRMAOANPC1
SCHEMBL23919483 0.91 MAOB (0.34) PGRTNKSPARP1TNKS2PARP2
SCHEMBL23919461 0.90 MEN1 (0.33) MEN1KMT2A
SCHEMBL23919462 0.90 TNKS (0.32) MEN1KMT2APGRTNKSPARP1
SCHEMBL23919504 0.90 GPR55 (0.33) GPR55CNR2
SCHEMBL24088725 0.90

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210320251-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE IDEMITSU KOSAN CO.,LTD. (JP) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210320251-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE OLA1, TAS2R19, TMEM109 MEN1 2129/4885KMT2A 236/4885PGR 4072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.